Fas-ligand gene silencing in basal cell carcinoma tissue with small interfering RNA. (Q40468769)

20 September 2017

title

Fas-ligand gene silencing in basal cell carcinoma tissue with small interfering RNA. (English)

1 reference

20 September 2017

0 references

Ji J

1 reference

20 September 2017

Wernli M

1 reference

20 September 2017

Mielgo A

1 reference

20 September 2017

Buechner SA

1 reference

20 September 2017

Erb P

1 reference

20 September 2017

publication date

1 April 2005

1 reference

20 September 2017

1 reference

20 September 2017

1 reference

20 September 2017

1 reference

20 September 2017

page(s)

678-684

1 reference

Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Fas ligand is expressed in normal skin and in some cutaneous malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Expression of CD40 and Fas ligand in Bowen's disease, squamous cell carcinoma and basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Direct in vivo transfection of antisense Fas-ligand reduces tumor growth and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Fas ligand downregulation with antisense oligonucleotides in cells and in cultured tissues of normal skin epidermis and basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

RNA interference is mediated by 21- and 22-nucleotide RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Modulation of HIV-1 replication by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Short interfering RNA confers intracellular antiviral immunity in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Short interfering RNA-directed inhibition of hepatitis B virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Inhibition of gammaherpesvirus replication by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Stable suppression of tumorigenicity by virus-mediated RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Specific inhibition of bcr-abl gene expression by small interfering RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Sequence-specific inhibition of small RNA function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

RNA interference may be more potent than antisense RNA in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Killing the messenger: short RNAs that silence gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

RNA-mediated gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

RNA interference: biology, mechanism, and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Small interfering RNA and gene silencing in transgenic mice and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

RNA interference in adult mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Inhibition of hepatitis B virus in mice by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Tissue-specific RNA interference in postimplantation mouse embryos with endoribonuclease-prepared short interfering RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

7 January 2021

siRNA-directed inhibition of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

7 January 2021

RNA interference targeting Fas protects mice from fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

7 January 2021

Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

7 January 2021

Gene silencing by systemic delivery of synthetic siRNAs in adult mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

7 January 2021

Ultraviolet light downregulates CD95 ligand and TRAIL receptor expression facilitating actinic keratosis and squamous cell carcinoma formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302453

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302453

1 reference

Dimensions Publication ID

20 September 2017

1050510348

0 references

1 reference